Pre-compliance Archives - Page 7 of 24 - Customs & International Trade Law Firm

Customs Valuation 101

What is Valuation and Why Does it Matter? Customs Valuation is a procedure to determine the customs value of imported goods. The customs value is essential to calculate the total duty to be paid on an imported good. Because there was a need for the international community to have a standardized system for valuing imports, many nations became signatories to a World Trade Organization (“WTO”) agreement that established valuation norms known as the Tokyo Round Valuation Code (later amended into the WTO Agreement on Implementation of Article VII of the GATT 1994).

The United States was a signatory to these treaties and currently maintains and enforces a rigorous valuation system. The U.S. Customs valuation methodology (as well as a summary of relevant Customs rulings) are described in detail in the Valuation Encyclopedia. A common customs valuation standard is important because it ensures that:

[…]

By Jennifer Diaz|2021-08-17T08:45:56-04:00August 17, 2021|Enforcement, Import, International Trade, penalty, Pre-compliance, Reasonable Care, Supply Chain, U.S. Customs and Border Protection (CBP)|0 Comments

Don’t Let FDA Target Your Medical Device Company

Did you know FDA has issued 1,569 enforcement actions against medical device companies? Now is the time to ensure your medical devices are in compliance with FDA laws and regulations prior to importation. If your business is manufacturing, repackaging, relabeling, and/or importing medical devices into the U.S., or wants to start, our one-hour webinar on “Importing Medical Devices in Compliance with U.S. FDA” is for you. We will provide TOP tips to avoid U.S. Food and Drug Administration (FDA) enforcement action, and best practices to navigate and mitigate FDA enforcement.

[…]

By Jennifer Diaz|2021-08-10T08:45:36-04:00August 10, 2021|Best Practices, COVID-19, Import, Import Alert, International Business, International Law, International Trade, Labeling, Medical Devices, PPE, Pre-compliance, Speaking, U.S. Food and Drug Administration (FDA)|0 Comments

Jennifer Diaz Presenting at Global Trade Educational Conference 2021

The NCBFAA Educational Institute invites all global logistics professionals to its 7th Annual Global Trade Educational Conference (GTEC). This two-day event in Baltimore, MD will give customs brokers, freight forwarders, NVOCCs, OTI, service providers, importers, exporters and all global logistics professionals an opportunity to update themselves on industry developments and connect with colleagues new and old.

Join us IN PERSON in Baltimore, MD, July 26-27, 2021. NCBFAA NEI and hotel staff will be complying with all state and venue COVID-19 protocols so you can feel safe attending the event! Virtual attendance is available, so you can gain knowledge from anywhere!

[…]

By Jennifer Diaz|2021-07-29T11:56:47-04:00July 6, 2021|ACE, Best Practices, Brokers, CBP 28, CBP 29, CEE, Counterfeits, CTPAT, Currency Seizure, Customs Broker, Customs Expert, Detention, Enforcement, Forced Labor, Freight Forwarding, Import, Intellectual Property Rights, International Trade, IPR, Trademarks and Logos, ISF, Labeling, Liquidated damages, penalty, Pre-compliance, Seizure, Speaking, U.S. Customs and Border Protection (CBP)|0 Comments

Between a Rock and a Hard Place – Conflicting U.S. & EU Sanctions Policies Towards Iran

Co-Authored by Sharath Patil

Background on U.S. Sanctions Programs

The U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) administers a number of different sanctions programs. The purpose of U.S. sanctions programs is to advance U.S. foreign policy objectives and protect national security. Currently, OFAC administers 35 sanctions programs. These sanctions programs vary widely – some are comprehensive while others are highly selective.

[…]

By Jennifer Diaz|2022-07-08T09:42:43-04:00June 15, 2021|EAR, Export, Iran, Pre-compliance, U.S. Office of Foreign Assets Control (OFAC)|0 Comments

Potential Relief from China Tariffs Coming

Co-Authored by Sharath Patil

Background on Section 301 Tariffs

A key element of the U.S.-China trade war, initiated under the Trump administration and continuing through Biden’s first term, was the imposition of China tariffs under Section 301. Section 301 is a mechanism via which the President can retaliate against foreign countries that violate U.S. trade agreements or engage in acts that are “unjustifiable” or “unreasonable” and burden U.S. commerce. With regard to China, the U.S. Trade Representative (“USTR”) found that China’s acts, policies, and practices related to intellectual property and innovation are unreasonable or discriminatory and burden or restrict U.S. commerce. Accordingly, a broad set of tariffs were instituted. Section 301 tariffs for goods originating from China have been so expansive that U.S. Customs revenue has nearly doubled from $41.6 billion in FY 2018 to $71.9 billion in FY 2019 and $74.4 billion in FY 2020.

[…]

By Jennifer Diaz|2022-07-08T09:41:39-04:00June 7, 2021|Best Practices, China, China Trade War, Enforcement, Import, International Trade, List 4A, Pre-compliance, Trade Policy, U.S. Office of the United States Trade Representative (USTR)|0 Comments

Previous 678 Next